Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth. To date, there haven’t been many reliable ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
MarketBeat on MSN
CRISPR Therapeutics gains after earnings as pipeline hope grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings ...
The gene-editing technique known as CRISPR has accelerated biological and medical research in the last decade by allowing scientists to repair the DNA of human cells almost as simply as using a pair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results